Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Ishiguro, Nobuhisa ^a   Koseki, Naoko ^a   Kaiho, Miki ^a   Ariga, Tadashi ^a   Kikuta, Hideaki ^b   Togashi, Takehiro ^c   Oba, Koji ^d,e   Morita, Keisuke ^f   Nagano, Naoko ^g   Nakanishi, Masanori ^h   Hara, Kazuya ^h   Hazama, Kyosuke ⁱ   Watanabe, Toru ^j   Yamanaka, Tatsuru ^k   Sasaki, Satoshi ^l   Furuyama, Hideto ^m   Shibata, Mutsuo ⁿ   Shida, Satoru ^o   Ishizaka, Akihito ^p   Tabata, Yuichi ^q   Aoyagi, Hayato ^r   Naito, Hiroyuki ^s   Yoshioka, Mikio ^t   Horino, Atsuko ^u   Kenri, Tsuyoshi ^u   Okamura, Akiko ^v   Yamazaki, Shigeru ^v   Kajii, Naofumi ^v   Nagashima, Tetsuo ^v   Takahashi, Yutaka ^v   Konno, Mutsuko ^v   Takebayashi, Takeyasu ^v   Sawada, Hiroyuki ^v   Matsuzono, Yoshihiro ^v   Murashita, Mari ^v   Akutsu, Yasushi ^v   Tobise, Katsuyuki ^v   Tobise, Chie ^v   Yasojima, Koichi ^v   Tsuchida, Akira ^v   Kosugiyama, Kiyotaka ^v   Kinugawa, Yoshikazu ^v   Tahara, Yasuo ^v   Yasuda, Kazue ^v   Iizuka, Susumu ^v   Tonoki, Hidefumi ^v   Odagawa, Yasuhisa ^v   Oka, Toshiaki ^v   Narita, Mitsuo ^v   Ogasawara, Suguru ^v   Kuniya, Yoshinori ^v   Tsuda, Yoko ^v   Uetsuji, Noriyuki ^v   Itakura, Yoshihiro ^v   Tsuchiyama, Akira ^v   Azuma, Katsumi ^v   more..

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Touei Hospital   (Japan)

^c Sapporo Fukujuji Clinic   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

^f ASAHIKAWA RED CROSS HOSPITAL   (Japan)

^g Nagano Pediatric Clinic   (Japan)

^h Kushiro Red Cross Hospital   (Japan)

ⁱ Hazama Pediatric Clinic   (Japan)

^j Watanabe Kazuhiko Pediatric Clinic   (Japan)

^k Department of Pediatrics   (Japan)

^l JAPANESE RED CROSS SOCIETY   (Japan)

^m KYUSHU HOSPITAL   (Japan)

ⁿ HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^o Ebetsu City Hospital   (Japan)

^p Sumiyoshi Pediatric Clinic   (Japan)

^q Iwamizawa Pediatric and Gynecology Clinic   (Japan)

^r Obihiro Kyokai Hospital   (Japan)

^s Chitose City Hospital   (Japan)

^t KKR Sapporo Medical Center   (Japan)

^u NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^v NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; LEVOFLOXACIN; MACROLIDE; MINOCYCLINE; TOSUFLOXACIN; ANTIINFECTIVE AGENT; NAPHTHYRIDINE DERIVATIVE; QUINOLONE DERIVATIVE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFICACY; FEMALE; FEVER; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; MYCOPLASMA PNEUMONIA; NONHUMAN; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; CLINICAL TRIAL; DRUG EFFECTS; GENETICS; MICROBIAL SENSITIVITY TEST; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; MYCOPLASMA PNEUMONIAE; NAPHTHYRIDINES; PNEUMONIA, MYCOPLASMA; TREATMENT OUTCOME;

EID: 85015298614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173635     Document Type: Article

References (36)

1. Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infection. The Journal of antimicrobial chemotherapy. 2013; 68(3):506-11. https://doi.org/10.1093/jac/dks457 PMID: 23169891
2. Waites KB, Talkington DF. Mycoplasma pneumoniae and its role as a human pathogen. Clinical microbiology reviews. 2004; 17(4):697-728, table of contents. PubMed Central PMCID: PMC523564. https://doi.org/10.1128/CMR.17.4.697-728.2004 PMID: 15489344
3. Okazaki N, Narita M, Yamada S, Izumikawa K, Umetsu M, Kenri T, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitro. Microbiology and immunology. 2001; 45(8):617-20. Epub 2001/10/11. PMID: 11592636
4. Li X, Atkinson TP, Hagood J, Makris C, Duffy LB, Waites KB. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates. The Pediatric infectious disease journal. 2009; 28(8):693-6. Epub 2009/07/28. https://doi.org/10.1097/INF.0b013e31819e3f7a PMID: 19633515
5. Pereyre S, Charron A, Renaudin H, Bebear C, Bebear CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. Journal of clinical microbiology. 2007; 45(11):3534-9. Epub 2007/09/21. PubMed Central PMCID: PMC2168523. https://doi.org/10.1128/JCM.01345-07 PMID: 17881549
6. Eshaghi A, Memari N, Tang P, Olsha R, Farrell DJ, Low DE, et al. Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011. Emerging infectious diseases. 2013;19(9). PubMed Central PMCID: PMC3810904.
7. Dumke R, von Baum H, Luck PC, Jacobs E. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2010; 16(6):613-6. Epub 2009/09/22.
8. Chironna M, Sallustio A, Esposito S, Perulli M, Chinellato I, Di Bari C, et al. Emergence of macrolide-resistant strains during an outbreak of Mycoplasma pneumoniae infections in children. The Journal of antimicrobial chemotherapy. 2011; 66(4):734-7. Epub 2011/03/12. https://doi.org/10.1093/jac/dkr003 PMID: 21393214
9. Zhou Z, Li X, Chen X, Luo F, Pan C, Zheng X, et al. Macrolide-Resistant Mycoplasma pneumoniae in Adults in Zhejiang, China. Antimicrobial agents and chemotherapy. 2015; 59(2):1048-51. https://doi.org/10.1128/AAC.04308-14 PMID: 25451048
10. Ma Z, Zheng Y, Deng J, Ma X, Liu H. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China. Pediatric pulmonology. 2014; 49(7):695-700. https://doi.org/10.1002/ppul.22851 PMID: 23861188
11. Liu X, Jiang Y, Chen X, Li J, Shi D, Xin D. Drug resistance mechanisms of Mycoplasma pneumoniae to macrolide antibiotics. BioMed research international. 2014; 2014:320801. PubMed Central PMCID: PMC3925631. https://doi.org/10.1155/2014/320801 PMID: 24592385
12. Zhao F, Liu G, Wu J, Cao B, Tao X, He L, et al. Surveillance of macrolide-resistant Mycoplasma pneumoniae in Beijing, China, from 2008 to 2012. Antimicrobial agents and chemotherapy. 2013; 57(3):1521-3. PubMed Central PMCID: PMC3591905. https://doi.org/10.1128/AAC.02060-12 PMID: 23263003
13. Matsuda K, Narita M, Sera N, Maeda E, Yoshitomi H, Ohya H, et al. Gene and cytokine profile analysis of macrolide-resistant Mycoplasma pneumoniae infection in Fukuoka, Japan. BMC infectious diseases. 2013; 13:591. PubMed Central PMCID: PMC3883477. https://doi.org/10.1186/1471-2334-13-591 PMID: 24330612
14. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, et al. Therapeutic Efficacy of Macrolides, Minocycline, and Tosufloxacin against Macrolide-Resistant Mycoplasma pneumoniae Pneumonia in Pediatric Patients. Antimicrobial agents and chemotherapy. 2013; 57(5):2252-8. Epub 2013/03/06. https://doi.org/10.1128/AAC.00048-13 PMID: 23459497
15. Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC infectious diseases. 2012; 12:126. Epub 2012/06/02. PubMed Central PMCID: PMC3478186. https://doi.org/10.1186/1471-2334-12-126 PMID: 22650321
16. Ishiguro N, Koseki N, Kaiho M, Kikuta H, Togashi T, Oba K, et al. Regional Differences in Rates of Macrolide-Resistant Mycoplasma pneumoniae in Hokkaido, Japan. Japanese journal of infectious diseases. 2015.
17. Kawai Y, Miyashita N, Kubo M, Akaike H, Kato A, Nishizawa Y, et al. Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients. Antimicrobial agents and chemotherapy. 2013; 57(8):4046-9. PubMed Central PMCID: PMC3719750. https://doi.org/10.1128/AAC.00663-13 PMID: 23716043
18. Meyer Sauteur PM, Unger WW, Nadal D, Berger C, Vink C, van Rossum AM. Infection with and Carriage of Mycoplasma pneumoniae in Children. Front Microbiol. 2016; 7:329. PubMed Central PMCID: PMCPMC4803743. https://doi.org/10.3389/fmicb.2016.00329 PMID: 27047456
19. Suzuki S, Yamazaki T, Narita M, Okazaki N, Suzuki I, Andoh T, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrobial agents and chemotherapy. 2006; 50(2):709-12. Epub 2006/01/27. PubMed Central PMCID: PMC1366908. https://doi.org/10.1128/AAC.50.2.709-712.2006 PMID: 16436730
20. Matsubara K, Morozumi M, Okada T, Matsushima T, Komiyama O, Shoji M, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patients. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2009; 15(6):380-3. Epub 2009/12/17.
21. Zhou Y, Zhang Y, Sheng Y, Zhang L, Shen Z, Chen Z. More complications occur in macrolide-resistant than in macrolide-sensitive Mycoplasma pneumoniae pneumonia. Antimicrobial agents and chemotherapy. 2014; 58(2):1034-8. PubMed Central PMCID: PMC3910883. https://doi.org/10.1128/AAC.01806-13 PMID: 24277047
22. Miyashita N, Akaike H, Teranishi H, Ouchi K, Okimoto N. Macrolide-resistant Mycoplasma pneumoniae pneumonia in adolescents and adults: clinical findings, drug susceptibility, and therapeutic efficacy. Antimicrobial agents and chemotherapy. 2013; 57(10):5181-5. PubMed Central PMCID: PMC3811443. https://doi.org/10.1128/AAC.00737-13 PMID: 23896480
23. Komatsu H, Tsunoda T, Inui A, Sogo T, Fujisawa T. Characteristics of hospitalized children infected with macrolide-resistant Mycoplasma pneumoniae. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases 2014; 18(3):294-9.
24. Kawai Y, Miyashita N, Yamaguchi T, Saitoh A, Kondoh E, Fujimoto H, et al. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients. Respirology. 2012; 17(2):354-62. Epub 2011/11/15. https://doi.org/10.1111/j.1440-1843.2011.02102.x PMID: 22077195
25. Sakata H. [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae]. The Japanese journal of antibiotics. 2012; 65(3):173-9. Epub 2012/11/24. PMID: 23173293
26. Okada T, Morozumi M, Tajima T, Hasegawa M, Sakata H, Ohnari S, et al. Rapid effectiveness of minocycline or doxycycline against macrolide-resistant Mycoplasma pneumoniae infection in a 2011 outbreak among Japanese children. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 2012; 55(12):1642-9. Epub 2012/09/14.
27. Sanchez AR, Rogers RS 3rd, Sheridan PJ. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Int J Dermatol. 2004; 43(10):709-15. https://doi.org/10.1111/j.1365-4632.2004.02108.x PMID: 15485524
28. Grady RW. Systemic quinolone antibiotics in children: a review of the use and safety. Expert Opin Drug Saf. 2005; 4(4):623-30. https://doi.org/10.1517/14740338.4.4.623 PMID: 16011441
29. Committee for the Guidelines in Management of Respiratory Infectious Diseases in Children. Guidelines for the management of respiratory infectious diseases in children in Japan. Tokyo, Japan: Kyowa Kikaku Ltd.; 2011.(in Japanese)
30. Winchell JM, Thurman KA, Mitchell SL, Thacker WL, Fields BS. Evaluation of three real-time PCR assays for detection of Mycoplasma pneumoniae in an outbreak investigation. Journal of clinical microbiology. 2008; 46(9):3116-8. Epub 2008/07/11. PubMed Central PMCID: PMC2546712. https://doi.org/10.1128/JCM.00440-08 PMID: 18614663
31. Matsuoka M, Narita M, Okazaki N, Ohya H, Yamazaki T, Ouchi K, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in Japan. Antimicrobial agents and chemotherapy. 2004; 48(12):4624-30. Epub 2004/11/25. PubMed Central PMCID: PMC529214. https://doi.org/10.1128/AAC.48.12.4624-4630.2004 PMID: 15561835
32. Hayflick L. Tissue cultures and mycoplasmas. Texas reports on biology and medicine. 1965; 23:Suppl 1:285+.
33. Nakazawa S, Oka S, Sato H, Watanabe O, Niino K. [Effects of dry syrup minocycline (Minomycin 'Lederle') in the pediatric field]. The Japanese journal of antibiotics. 1972; 25(5):288-94. PMID: 4539520
34. Naline E, Sanceaume M, Toty L, Bakdach H, Pays M, Advenier C. Penetration of minocycline into lung tissues. Br J Clin Pharmacol. 1991; 32(3):402-4. PubMed Central PMCID: PMCPMC1368539. PMID: 1777379
35. Sunakawa K, Iwai N, Iwata S, Ouchi K, Sakata H, Suzuki K, et al. Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases. Jpn J Chemother. 2010; 58(S-2):69-77.
36. Nasu M, Yamazaki T, Yamazaki H, Kuroda Y, Goto Y, Shigeno H, et al. T-3262 in respiratory tract infections. Chemotherapy. 1988; 36(S-9):699-709. (in Japanese)